首页 | 本学科首页   官方微博 | 高级检索  
     


A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication
Authors:Sérgio Vencio MD  Rafael Caiado-Vencio MD  Leonardo Ferreira Caixeta MD  Małgorzata Masierek MD  Wojciech Mlynarski MD  Józef Drzewoski MD  Justin M. Gregory MD
Affiliation:1. UFG - Federal University of Goiás, Aparecida de Goiania, Brazil;2. Pontifical Catholic University of Goiás, Aparecida de Goiania, Brazil;3. Bioton S.A., Macierzysz, Warsaw, Poland;4. Medical University of Lodz, Lodz, Poland;5. Vanderbilt University Medical Center, Nashville, Tennessee, USA
Abstract:
Keywords:pharmacokinetics  pharmacodynamics  type 1 diabetes  insulin therapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号